Cara Therapeutics (CARA) Tops Q3 EPS by 5c

November 3, 2016 4:23 PM EDT
Get Alerts CARA Hot Sheet
Trade CARA Now!
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Cara Therapeutics (NASDAQ: CARA) reported Q3 EPS of ($0.42), $0.05 better than the analyst estimate of ($0.47).

For earnings history and earnings-related data on Cara Therapeutics (CARA) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment